Logo

Lunaphore: Joseph Bernardo

Aug 30, 2019

Lausanne, Switzerland-based Lunaphore Technologies has appointed Joseph Bernardo chairman of its board of directors. Bernardo has a leadership background spanning the diagnostic value chain, including laboratory management, sales, service, marketing, distribution, operations, and R&D. Bernardo has held four president positions at Thermo Fisher Scientific, including in the divisions of Next Generation Sequencing, Immunodiagnostics, Anatomic Pathology, and Fisher Healthcare. In addition to his operational executive experience in diagnostics, Bernardo has significant M&A experience and has been involved in more than 40 due diligence assessments, acquisitions, and company integrations, Lunaphore said.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.